189 related articles for article (PubMed ID: 11836703)
21. Discriminating hepatocellular carcinoma from metastatic carcinoma on fine-needle aspiration biopsy of the liver: the utility of immunocytochemical panel.
Saleh HA; Aulicino M; Zaidi SY; Khan AZ; Masood S
Diagn Cytopathol; 2009 Mar; 37(3):184-90. PubMed ID: 19170172
[TBL] [Abstract][Full Text] [Related]
22. Utility of pancreatic digestive enzyme immunohistochemistry in the differential diagnosis of hepatocellular carcinoma, cholangiocarcinoma and metastatic adenocarcinoma of the liver.
Terada T; Nakanuma Y
Pathol Int; 1996 Mar; 46(3):183-8. PubMed ID: 10846568
[TBL] [Abstract][Full Text] [Related]
23. Diagnostic utility of CD10 immunohistochemical staining on cellblock in differentiating hepatocellular carcinoma from secondary malignancies of liver.
Singha J; Khan K; Chatterjee S
Indian J Pathol Microbiol; 2018; 61(4):510-515. PubMed ID: 30303139
[TBL] [Abstract][Full Text] [Related]
24. Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma.
Röcken C; Licht J; Roessner A; Carl-McGrath S
J Clin Pathol; 2005 Oct; 58(10):1069-75. PubMed ID: 16189153
[TBL] [Abstract][Full Text] [Related]
25. Cytodiagnosis of hepatocellular carcinoma in fine-needle aspirates of the liver: its differentiation from reactive hepatocytes and metastatic adenocarcinoma.
Das DK
Diagn Cytopathol; 1999 Dec; 21(6):370-7. PubMed ID: 10572267
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic value of hepatocyte paraffin 1 antibody to discriminate hepatocellular carcinoma from metastatic carcinoma in fine-needle aspiration biopsies of the liver.
Zimmerman RL; Burke MA; Young NA; Solomides CC; Bibbo M
Cancer; 2001 Aug; 93(4):288-91. PubMed ID: 11507703
[TBL] [Abstract][Full Text] [Related]
27. Hep par-1: a novel immunohistochemical marker for differentiating hepatocellular carcinoma from metastatic carcinoma.
Hanif R; Mansoor S
J Coll Physicians Surg Pak; 2014 Mar; 24(3):186-9. PubMed ID: 24613115
[TBL] [Abstract][Full Text] [Related]
28. Diagnostic utility of Glut-1 and CA 15-3 in discriminating adenocarcinoma from hepatocellular carcinoma in liver tumors biopsied by fine-needle aspiration.
Zimmerman RL; Burke M; Young NA; Solomides CC; Bibbo M
Cancer; 2002 Feb; 96(1):53-7. PubMed ID: 11836704
[TBL] [Abstract][Full Text] [Related]
29. Use of CD34 and factor VIII to diagnose hepatocellular carcinoma on fine needle aspirates.
Gottschalk-Sabag S; Ron N; Glick T
Acta Cytol; 1998; 42(3):691-6. PubMed ID: 9622689
[TBL] [Abstract][Full Text] [Related]
30. A comparison of CD10 to pCEA, MOC-31, and hepatocyte for the distinction of malignant tumors in the liver.
Morrison C; Marsh W; Frankel WL
Mod Pathol; 2002 Dec; 15(12):1279-87. PubMed ID: 12481008
[TBL] [Abstract][Full Text] [Related]
31. Combined hepatocellular-cholangiocarcinoma. Diagnostic challenge in hepatic fine needle aspiration biopsy.
Wee A; Nilsson B
Acta Cytol; 1999; 43(2):131-8. PubMed ID: 10097699
[TBL] [Abstract][Full Text] [Related]
32. Loss of 5-hydroxymethylcytosine immunohistochemical expression is a useful diagnostic aid for distinguishing hepatocellular carcinoma in cytology fine needle aspiration specimens.
Zhu X; Dresser K; Chen BJ
Cytopathology; 2019 Sep; 30(5):492-498. PubMed ID: 31081979
[TBL] [Abstract][Full Text] [Related]
33. Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver.
Lei JY; Bourne PA; diSant'Agnese PA; Huang J
Am J Clin Pathol; 2006 Apr; 125(4):519-25. PubMed ID: 16627262
[TBL] [Abstract][Full Text] [Related]
34. Role of CD10 immunochemistry in differentiating hepatocellular carcinoma from metastatic carcinoma of the liver.
Ahuja A; Gupta N; Kalra N; Srinivasan R; Chawla Y; Rajwanshi A
Cytopathology; 2008 Aug; 19(4):229-35. PubMed ID: 18070122
[TBL] [Abstract][Full Text] [Related]
35. Hepatocyte antigen as a marker of hepatocellular carcinoma: an immunohistochemical comparison to carcinoembryonic antigen, CD10, and alpha-fetoprotein.
Chu PG; Ishizawa S; Wu E; Weiss LM
Am J Surg Pathol; 2002 Aug; 26(8):978-88. PubMed ID: 12170084
[TBL] [Abstract][Full Text] [Related]
36. Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma.
Lau SK; Prakash S; Geller SA; Alsabeh R
Hum Pathol; 2002 Dec; 33(12):1175-81. PubMed ID: 12514785
[TBL] [Abstract][Full Text] [Related]
37. Two-color immunostaining of liver fine needle aspiration biopsies with CD34 and carcinoembryonic antigen. Potential utilization in the diagnosis of primary hepatocellular carcinoma vs. metastatic tumor.
Yoder M; Zimmerman RL; Bibbo M
Anal Quant Cytol Histol; 2004 Apr; 26(2):61-4. PubMed ID: 15131892
[TBL] [Abstract][Full Text] [Related]
38. KL-6 mucin is a useful immunohistochemical marker for cholangiocarcinoma.
Tang W; Guo Q; Qu X; Inagaki Y; Seyama Y; Midorikawa Y; Gai R; Kokudo N; Sugawara Y; Nakata M; Makuuchi M
Oncol Rep; 2007 Apr; 17(4):737-41. PubMed ID: 17342308
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical Assessment of the Expression of Biliary Transportation Proteins MRP2 and MRP3 in Hepatocellular Carcinoma and in Cholangiocarcinoma.
Cirqueira CS; Felipe-Silva AS; Wakamatsu A; Marins LV; Rocha EC; de Mello ES; Alves VAF
Pathol Oncol Res; 2019 Oct; 25(4):1363-1371. PubMed ID: 29464551
[TBL] [Abstract][Full Text] [Related]
40. Fibrolamellar Carcinoma With Predominantly Pseudoglandular Architecture: A Potential Diagnostic Pitfall.
du Toit M; Aldera AP
Int J Surg Pathol; 2021 Feb; 29(1):69-72. PubMed ID: 32508199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]